Kiniksa Pharmaceuticals Ltd (KNSA) Price Targets From Analysts
Use the tables below to see what analysts covering Kiniksa Pharmaceuticals Ltd think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $37 | $25 | $32.75 | $14.73 | 122.34% |
The Trend in the Analyst Price Target
KNSA's average price target has moved down $4.25 over the prior 207 days.
KNSA reports an average of 82.33% for its upside potential over the past 338 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-08 | 4 | 37 | 25 | 32.75 | 14.63 | 123.86% |
| 2021-04-22 | 5 | 40 | 25 | 34.20 | 16.54 | 106.77% |
| 2021-04-17 | 5 | 40 | 25 | 34.20 | 15.63 | 118.81% |
| 2021-04-10 | 5 | 40 | 25 | 34.20 | 17.69 | 93.33% |
| 2021-04-03 | 5 | 40 | 25 | 34.20 | 18.48 | 85.06% |
| 2021-03-20 | 6 | 40 | 25 | 34.33 | 20.14 | 70.46% |
| 2021-03-13 | 6 | 40 | 14 | 32.17 | 23.22 | 38.54% |
| 2021-03-06 | 6 | 40 | 25 | 34.00 | 22.37 | 51.99% |
| 2021-02-27 | 6 | 40 | 25 | 34.00 | 20.57 | 65.29% |
| 2021-02-04 | 6 | 40 | 25 | 34.00 | 20.54 | 65.53% |
| 2021-01-30 | 6 | 40 | 25 | 34.00 | 19.69 | 72.68% |
| 2021-01-23 | 6 | 40 | 25 | 34.00 | 18.27 | 86.1% |
| 2021-01-16 | 6 | 40 | 25 | 34.00 | 19.85 | 71.28% |
| 2021-01-09 | 6 | 40 | 25 | 34.00 | 18.98 | 79.14% |
| 2021-01-02 | 6 | 40 | 25 | 34.00 | 17.67 | 92.42% |
| 2020-12-26 | 6 | 40 | 25 | 34.00 | 19.00 | 78.95% |
| 2020-12-19 | 6 | 40 | 25 | 34.00 | 19.40 | 75.26% |
| 2020-12-10 | 6 | 40 | 25 | 34.00 | 18.09 | 87.95% |
| 2020-12-07 | 6 | 40 | 25 | 34.00 | 17.45 | 94.84% |
| 2020-11-28 | 6 | 40 | 25 | 34.00 | 18.26 | 86.2% |
| 2020-11-13 | 4 | 35 | 34 | 34.75 | 15.65 | 122.04% |
| 2020-10-13 | 4 | 40 | 34 | 37.00 | 20.62 | 79.44% |
| 2020-09-09 | 4 | 40 | 34 | 37.00 | 15.95 | 131.97% |
| 2020-08-16 | 4 | 40 | 34 | 37.00 | 17.70 | 109.04% |
| 2020-07-30 | 5 | 40 | 34 | 37.60 | 19.62 | 91.64% |
| 2020-07-22 | 5 | 40 | 33 | 37.80 | 21.35 | 77.05% |
| 2020-07-16 | 5 | 40 | 33 | 37.80 | 22.12 | 70.89% |
| 2020-07-05 | 5 | 40 | 33 | 37.40 | 23.73 | 57.61% |
| 2020-06-29 | 5 | 40 | 33 | 37.40 | 26.00 | 43.85% |
| 2020-06-04 | 5 | 40 | 25 | 30.00 | 21.14 | 41.91% |
KNSA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 2 | 3 | 0 | 0 | 0 | 5 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The upside potential (average analyst target price relative to current price) of KNSA is greater than 85.04% of all US stocks.
- KNSA has a higher average analyst price target than 72.39% of stocks in the small market cap category.
- KNSA has a less variance in analysts' estimates than 31.07% of stocks in the small market cap category.
- The number of analysts covering the stock of KNSA is greater than 34.45% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Kiniksa Pharmaceuticals Ltd are ITOS, SURF and DYN.
Is KNSA a Buy, Hold or Sell? See the POWR Ratings now!